Skip to search formSkip to main contentSkip to account menu

ciamexon

Known as: (+-)-1-((2-Methoxy-6-methyl-3-pyridyl)methyl)-2-aziridinecarbonitrile, ciamexone, 2-cyan-1-((2-methoxy-6-methylpyridin-3-yl)methyl)aziridine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
1. The in vitro generation of stable, protein-reactive and cytotoxic metabolites from ciamexon by human liver microsomes has been… 
1989
1989
1989
The follow-up of Graves' ophthalmopathy was analysed regarding to clinical and chemical data on the one hand and to dependence on… 
1987
1987
In severe cases of e.o. IV to VI combined treatment with Cyclosporin A and corticosteroids is most effective whereas Ciamixon… 
1987
1987
Presently Graves’ ophthalmopathy is considered to be an organ specific autoimmune disorder as shown by Wang et al. (1) and Volpe… 
Review
1986
Review
1986
AbstractProf. Dr. med. W. Schaumann dedicated on the occasion of his 60th birthday on November 20, 1986The interaction of T… 
1986
1986
SummaryBoth organ-specific diseases such as insulin dependent diabetes mellitus as well as non organ-specific disorders such as…